Segment disclosures

Company overview

LIPOCINE INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 12 retained observations 9 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=LPCN:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-311976677 USD20260310Open filing evidence
2025-07-01 – 2025-09-30114574 USD20251106Open filing evidence
2025-01-01 – 2025-09-30831287 USD20251106Open filing evidence
2025-04-01 – 2025-06-30622849 USD20250805Open filing evidence
2025-01-01 – 2025-06-30716713 USD20250805Open filing evidence
2025-01-01 – 2025-03-3193864 USD20250508Open filing evidence
2024-01-01 – 2024-12-3111198144 USD20260310Open filing evidence
2024-01-01 – 2024-09-307706738 USD20251106Open filing evidence
2024-04-01 – 2024-06-3089565 USD20250805Open filing evidence
2024-01-01 – 2024-06-307706738 USD20250805Open filing evidence
2024-01-01 – 2024-03-317617174 USD20250508Open filing evidence
2023-01-01 – 2023-12-31-2850818 USD20250313Open filing evidence